HomeNewsVideos

Ministry of Industry continues to boost domestic pharmaceutical industry

12 March 2020 08:16

JAKARTA - The Ministry of Industry continues to encourage the domestic pharmaceutical industry to increase their research activities so that they can produce highly competitive product innovations. This step is expected to meet the needs of the domestic market and export demand.

"We want to strengthen the structure of the domestic pharmaceutical industry. One of them is through research activities, such as for the development of herbal medicines,” said Industry Minister Agus Gumiwang Kartasasmita during a working visit at PT Dexa Laboratories of Biomolecular Science, Cikarang, Bekasi, West Java, Wednesday (11/3).

The Minister of Industry gave appreciation to Dexa Group as a leading pharmaceutical company in Indonesia which was established in 1969 and is able to provide a variety of quality pharmaceutical products. Dexa Group's products are not only for local consumers, but have also been exported to various countries on four continents, namely Africa, Asia, America and Europe.

Agus added, he was determined to continue to grow the pharmaceutical industry sector in the country by expanding market access and increasing its utilization. Then, the Ministry of Industry also encourages the efforts of the pharmaceutical industry to reduce imports of raw materials and produce substitutes. Furthermore, the Minister of AGK supports the socialization Original Indonesian Modern Medicine (OMAI).

The Ministry of Industry noted, in the fourth quarter of 2019, the chemical, pharmaceutical and traditional medicine industries could grow 18.57% or jump dramatically compared to the quarter III-2019 growth which touched 9.47%. This achievement also exceeded 4.97% of economic growth in the fourth quarter of 2019. During 2019, the export value of the pharmaceutical industry and traditional medicine products penetrated up to USD 597.7 million, an increase compared to the acquisition in the previous year of around USD 571.1 million. (LM)

© 2024 - IDN Financials - All Rights Reserved.